Authors: Gourdeau, H Bibeau, L Ouellet, F Custeau, D Bernier, L Bowlin, T

Citation: H. Gourdeau et al., Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine,BCH-4556) and AraC against leukemic human tumor xenografts expressing highor low cytidine deaminase activity, CANC CHEMOT, 47(3), 2001, pp. 236-240

Authors: Labonte, P Kadhim, S Bowlin, T Mounir, S

Citation: P. Labonte et al., Inhibition of tumor growth with doxorubicin in a new orthotopically implanted human hepatocellular carcinoma model, HEPATOL RES, 18(1), 2000, pp. 72-85

Authors: Taylor, DL Ahmed, PS Chambers, P Tyms, AS Bedard, J Duchaine, J Falardeau, G Lavallee, JF Brown, W Rando, RF Bowlin, T

Citation: Dl. Taylor et al., Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1, ANTIVIR CHE, 10(2), 1999, pp. 79-86

Authors: Bedard, J May, S Lis, M Tryphonas, L Drach, J Huffman, J Sidwell, R Chan, L Bowlin, T Rando, R

Citation: J. Bedard et al., Comparative study of the anti-human cytomegalovirus activities and toxicities of a tetrahydrofuran phosphonate analogue of guanosine and cidofovir, ANTIM AG CH, 43(3), 1999, pp. 557-567